Baldwin C - Search Results

1

Optimization of human immunodeficiency virus type 1 envelope glycoproteins with V1/V2 deleted, using virus evolution.

Bontjer I, Land A, Eggink D, Verkade E, Tuin K, Baldwin C, Pollakis G, Paxton WA, Braakman I, Berkhout B, Sanders RW. Bontjer I, et al. Among authors: baldwin c. J Virol. 2009 Jan;83(1):368-83. doi: 10.1128/JVI.01404-08. Epub 2008 Oct 15. J Virol. 2009. PMID: 18922866 Free PMC article.

2

Mechanistic studies of a T20-dependent human immunodeficiency virus type 1 variant.

Baldwin C, Berkhout B. Baldwin C, et al. J Virol. 2008 Aug;82(15):7735-40. doi: 10.1128/JVI.02524-07. Epub 2008 May 14. J Virol. 2008. PMID: 18480456 Free PMC article.

3

Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor.

Baldwin CE, Sanders RW, Deng Y, Jurriaans S, Lange JM, Lu M, Berkhout B. Baldwin CE, et al. J Virol. 2004 Nov;78(22):12428-37. doi: 10.1128/JVI.78.22.12428-12437.2004. J Virol. 2004. PMID: 15507629 Free PMC article.

4

Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.

Das AT, Baldwin CE, Vink M, Berkhout B. Das AT, et al. J Virol. 2005 Mar;79(6):3855-8. doi: 10.1128/JVI.79.6.3855-3858.2005. J Virol. 2005. PMID: 15731280 Free PMC article.

5

Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein.

Baldwin CE, Berkhout B. Baldwin CE, et al. Retrovirology. 2006 Nov 29;3:84. doi: 10.1186/1742-4690-3-84. Retrovirology. 2006. PMID: 17134507 Free PMC article.

6

Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells.

Sanders RW, de Jong EC, Baldwin CE, Schuitemaker JH, Kapsenberg ML, Berkhout B. Sanders RW, et al. Among authors: baldwin ce. J Virol. 2002 Aug;76(15):7812-21. doi: 10.1128/jvi.76.15.7812-7821.2002. J Virol. 2002. PMID: 12097593 Free PMC article.

7

Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.

Groot F, Geijtenbeek TB, Sanders RW, Baldwin CE, Sanchez-Hernandez M, Floris R, van Kooyk Y, de Jong EC, Berkhout B. Groot F, et al. Among authors: baldwin ce. J Virol. 2005 Mar;79(5):3009-15. doi: 10.1128/JVI.79.5.3009-3015.2005. J Virol. 2005. PMID: 15709021 Free PMC article.

8

Selection of T1249-resistant human immunodeficiency virus type 1 variants.

Eggink D, Baldwin CE, Deng Y, Langedijk JP, Lu M, Sanders RW, Berkhout B. Eggink D, et al. J Virol. 2008 Jul;82(13):6678-88. doi: 10.1128/JVI.00352-08. Epub 2008 Apr 23. J Virol. 2008. PMID: 18434391 Free PMC article.

9

HIV-1 drug-resistance and drug-dependence.

Baldwin C, Berkhout B. Baldwin C, et al. Retrovirology. 2007 Oct 25;4:78. doi: 10.1186/1742-4690-4-78. Retrovirology. 2007. PMID: 17961213 Free PMC article. Review.

10

Inhibiting HIV-1 entry with fusion inhibitors.

Baldwin CE, Sanders RW, Berkhout B. Baldwin CE, et al. Curr Med Chem. 2003 Sep;10(17):1633-42. doi: 10.2174/0929867033457124. Curr Med Chem. 2003. PMID: 12871113 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,046 results

Search Page

Filters